EVALUATION THE EFFECT OF METFORMIN ON HORMONES SERUM LEVELS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
DOI:
https://doi.org/10.25130/tjps.v22i9.865Keywords:
PCOS, Metformin, FSH, LH, Prolactin, TestosteroneAbstract
Background: Polycystic ovary syndrome [PCOS] is a common disease that affected the reproductive problem. Aim: the study tried to determine the association between PCOS with the body mass index (BMI) and the effect of metformin as treatment for PCOS.
Patients and Methods: This case control prospective experimental study was carried out in Kirkuk General Hospital from January 2014 to July 2014. The recruited cases divided into three groups; Group I, 68 women with normal menstrual cycle as control group; Group II, 61 cases diagnosed as a PCOS; and Group III :- 30 cases selected from group two to receive treatment with Metformin to determine the effect of the treatment on different variables. Results: The highest percentage of PCOS (36.1%) was found in those with age group between (20-25) years. Most (65.6%) of PCOS subjects were with overweight or obese. BMI mean value was (28.92±6.68) in women with PCOS, while in control the corresponding value was (25.09±4.35). FSH, and testosterone were significantly higher in women with PCOS than in control. Metformin reduced serum FSH, LH, prolactin and testosterone, with non-significant difference. Conclusion: PCOS is independently associated with elevated BMI. Metformin treatment of PCOS induced t reduction in serum testosterone and FSH, LH and serum prolactin but not reach significant level. This warranted performance a large scale clinical trial to evaluate the therapeutic effect of metformin alone or in combination with diet control approach for treatment of PCOS. These findings have implications for the pathophysiology of obesity development and management in PCOS.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Tikrit Journal of Pure Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
